Research and Markets: Sri Lanka Pharma Market Outlook 2015: More Beyond Importers & Distributors
March 05 2015 - 5:21AM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/qnntb5/sri_lanka_pharma)
has announced the addition of the "Sri Lanka Pharma Market Outlook
2015: More beyond Importers & Distributors" report to their
offering.
With the recent development, Sri Lanka's aim of developing a
pharma industry should be to penetrate the global market since the
internal market is not sufficient for any big firm to operate at
optimum levels. According to a report published by Indian Council
on International Relations in Dec. 14, the global market of pharma
is about $1trillion, and India's export of pharma products in 2013
amounted to $13bn, where as Sri Lanka was nil. Hence, pharma
industry offers a very valuable opportunity for Sri Lanka to
diversify its manufacturing and export base and thereby reach the
goal of upper middle income country by 2020 and a rich country by
2035.
Sri Lanka's free healthcare policy practiced by successive
governments ensures that this arena continues to be dominated by
the government sector. Meanwhile, the relatively smaller public
counterpart, i.e. the private sector has increasingly contributed
towards serving the healthcare needs of the country. Sri Lanka's
total expenditure on health has increased by -11%, CAGR
(2005-2010), and this has been driven by both private- (+12%) and
government-sector (+10%) spending. Notwithstanding the state
sector's dominance, private sector expenditure on health has
continued to rise, contributing an estimated 55% to total
expenditure.
In this report, we highlight the economy, demography, past and
emerging trend of pharma industry, and availability of basic
resources. This report also provides current disease prevalence and
incidence along with the country's healthcare system and also
discuss about future market opportunities. Furthermore, the report
explains current medical supply and product accessibility in Govt.
and Private sectors along with physicians prescribing pattern and
price control. Local manufacturing and role of Govt. support to
local manufacturers, regulatory and insurance framework are also
discussed in this report.
Key Topics Covered:
1. Executive Summary
2. Overview: Sri Lanka
a. Demography
b. Economy
c. Disease prevalence and Incidence
d. Healthcare systems - Opportunities & Challenges
3. Synopsis of Sri Lankan Pharmaceutical Market
a. Pharmaceutical Market Size and Historical Growth data
b. Availability of Basic Resources and Support Systems
c. Future Growth
4. Medicine Supply and Accessibility
a. Government (MSD) purchase of hospital supplies through SPC
Tender
b. Private market
5. Current Status of Pharmaceutical Manufacturing in Sri
Lanka
a. Local Players
b. Foreign players
6. Regulatory, Pricing, Insurance Framework
Companies Mentioned
- National Drugs Quality Assurance Laboratory
- NCD
- National Hospital of Sri Lanka
For more information visit
http://www.researchandmarkets.com/research/qnntb5/sri_lanka_pharma
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals, Generics